日本語 
Contrea Inc., which provides the patient care digital transformation platform “MediOS” to medical institutions, is pleased to announce that it has raised a total of 950 million yen in Series A funding through a third-party allotment of new shares to existing shareholders and new investors, with ITOCHU Technology Ventures as the lead investor, as well as loans from financial institutions.
Contrea is a medical startup whose mission is to “provide peace of mind to everyone involved in medical care.”
We provide “Patient DX Medios,” which provides end-to-end support for interactions between medical professionals and patients. Medios is primarily used in acute care hospitals and regional core hospitals, with an utilization rate of approximately 15% at university hospitals.
Based on the experience we have cultivated so far, we have raised funds to further address medical issues in Japan and around the world.
Also Read: Opt Fit Unveils “And L Work” for Corporate Health Support
Japan’s medical industry is facing a serious labor shortage due to increased demand caused by a declining birthrate and aging population, and a shrinking workforce, with a projected shortage of approximately 1.87 million medical personnel by 2030.
Furthermore, work style reforms for doctors will come into effect on April 1, 2024, and the working styles of doctors and other medical professionals will be revised. Until now, long working hours have been used to compensate for labor shortages, but these reforms will limit working hours, making the labor shortage even more serious.
SOURCE: PRTimes
English